Amdocs

Amdocs: KDJ Death Cross and Bearish Marubozu on 15-Minute Chart

Amdocs's 15-minute chart shows RSI Oversold, KDJ Golden Cross.

Amdocs Triggers MACD Death Cross, KDJ Death Cross on 15-Minute Chart

Amdocs 15min chart: Bollinger Bands narrowing, KDJ death cross observed.

Catalyst<ul> <li>Most analysts rate DOX Buy or Strong Buy, showing broad institutional optimism.</li></ul>Risk<ul> <li>At least one major firm maintains a Neutral rating, citing valuation concerns.</li> <li>Fund flow trends show an overall negative net outflow, indicating investor caution.</li></ul>

Key Factors

DOX faces a critical juncture ahead of its Q1 2026 earnings report as analysts project a 23.69% upside potential with a $104 fair value target. DOX reported a 9% year-over-year revenue decline in Q4 2025 but achieved an 83% increase in operating income, highlighting a pivot toward profitability. DOX raised its quarterly dividend to $0.569 per share, offering a 2.03% yield, reflecting its focus on income appeal amid margin expansion.

DOX News